Related Experiment Video
Updated: Jul 14, 2026

08:53
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Development of poly(amino ester glycol urethane)/siRNA polyplexes for gene silencing
1Department of Chemical Engineering, National Tsing Hua University, 101, Sec. 2, Kuang Fu Road, Hsinchu 300, Taiwan.
Bioconjugate Chemistry
|June 15, 2007
Summary
This study developed novel poly(amino ester glycol urethane) (PaE(G)U) nonviral vectors for efficient siRNA delivery. These PaE(G)U/siRNA polyplexes achieved significant gene silencing in a cellular model.
Area of Science:
- Biotechnology
- Polymer Chemistry
- Gene Therapy
Background:
- Nonviral vectors offer safer alternatives for siRNA therapy due to low immunogenicity and pathogenicity.
- Poly(ester urethane)s functionalized with tertiary amines and polyethylene glycol (PEG) were previously developed as DNA transfection reagents.
- The need for effective nonviral carriers for small interfering RNA (siRNA) delivery remains a key challenge in gene silencing.
Purpose of the Study:
- To develop and optimize poly(amino ester glycol urethane) (PaE(G)U)/siRNA polyplexes for efficient gene silencing.
- To characterize the properties of PaE(G)U/siRNA polyplexes and compare them with PaE(G)U/DNA polyplexes.
- To evaluate the gene silencing efficacy of the developed PaE(G)U/siRNA polyplexes in a cellular model.
Main Methods:
- Synthesis of soluble poly(amino ester glycol urethane) (PaE(G)U) incorporating tertiary amines and PEG.
- Formation and characterization of PaE(G)U/siRNA polyplexes, including size determination.
- Visualization of cellular uptake using fluorescently labeled siRNA and assessment of gene silencing via luciferase reporter assay.
Main Results:
- PaE(G)U/siRNA polyplexes were successfully formed with an optimized mass ratio of 80/1, resulting in an average diameter of 540 nm.
- Cellular uptake of PaE(G)U/siRNA polyplexes was visualized and optimized.
- Transient silencing of constitutive luciferase expression up to 92% was achieved in HT-1080 fibroblasts using anti-luciferase siRNA delivered by PaE(G)U/siRNA polyplexes.
Conclusions:
- PaE(G)U/siRNA polyplexes are effective nonviral carriers for gene silencing applications.
- The engineering of soluble, biodegradable polymers with specific functional units (amino, ester, PEG, urethane) is a promising strategy for designing novel siRNA carriers.
- Optimized PaE(G)U/siRNA polyplexes demonstrate potential for safer and efficient siRNA-based gene therapy.
Related Concept Videos
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

